It is currently Sun Apr 19, 2015 4:03 am

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Tovaxin Update/Trial

This from BBC news.


MS vaccine testing to start in US

Researchers are working towards having an MS vaccine
A US company is set to begin a trial of a vaccine which it claims halts the progress of multiple sclerosis.

PharmaFrontiers is to test its tailor-made vaccine on 100 patients with MS, after a small-scale study showed promise, New Scientist reports.

MS experts have welcomed the research but urged caution because other vaccines have not ...
Read more : Tovaxin Update/Trial | Views : 1647 | Replies : 3


The pharma industry

I read postings on this forum on a regular basis and quite often it amases me. We all have an awful disease and it is a rough ride. But i think we are very quick to judge..

common themes include

Anti - CRABS (well I'm on copaxone and doing great - I know its not for everyone, but I cant be the only one who is doing well on it? OK so its not a ...
Read more : The pharma industry | Views : 2604 | Replies : 12


Generic interferons

Not that anybody is excited about interferons, but if they must be taken at least they might be about to get cheaper...



Ratiopharm: competes with Stada, Sandoz on biogeneric drugs

Mar 8, 2006 - Marketwatch - German generic drug maker Ratiopharm GmbH Wednesday said it is competing with German generics company Stada AG and Novartis AG's generic subsidiary Sandoz in the race for biogeneric drugs to be approved in Europe.

Although the company, which had ...
Read more : Generic interferons | Views : 1342 | Replies : 0


Neurocrine APL

Dignan,

If this was on the list you need to erase it.

Ian

http://c.moreover.com/click/here.pl?j482124809&w=464753
Read more : Neurocrine APL | Views : 1344 | Replies : 1


MBP8298 update

This sounds promising, although they don't provide much information here...



BioMS Medical's MBP8298 Shows Five-year Delay of Disease Progression in Patients with Multiple Sclerosis

March 7, 2006- BioMS Medical today announced that its proprietary drug candidate MBP8298 delayed disease progression for five years in progressive MS patients with HLA-DR2 or HLA-DR4 immune response genes.

Treatment and follow-up of patients from a phase II clinical study demonstrated that patients in this DR2 and DR4 responder group, ...
Read more : MBP8298 update | Views : 1295 | Replies : 1


MBP8298 Encouraging Results

Very encouraging results for disease progression from its phase II study! Hopefully this pans out with the phase II/III which they are now enrolling.

Original link:
http://biz.yahoo.com/cnw/060307/bioms_s ... .html?.v=1

Dunmann.


BioMS Medical's MBP8298 shows five-year delay of disease progression in patients with multiple sclerosis
Tuesday March 7, 8:55 am ET

-Results to be presented at the American Academy of Neurology April 4, 2006-
Toronto Stock Exchange Symbol: MS
EDMONTON, ...
Read more : MBP8298 Encouraging Results | Views : 1145 | Replies : 0


NNZ-2566

I have previously posted articles relating to Neuren Pharmaceuticals. Much of their research focuses on neuro-protection. Their website states that:

"The compounds developed by Neuren have application not only to acute brain injuries associated with stroke, cardiopulmonary bypass surgery (CPB) and traumatic brain injury but also in chronic neurological conditions such as Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis".

Their first key drug, Glypromate, is in Phase 2 trials (with the US Army). The company ...
Read more : NNZ-2566 | Views : 1227 | Replies : 0


Rituximab / Rituxin

I have posted before on Rituximab which is being trialled in PP, SP and RR MS. The FDA has just approved Rituximab for Rheumatoid Arthritis. Rituximab targets the B cells which are now thought to be involved in MS. If the trials for MS do prove promising then I imagine approval might be speedier as it has been approved for eight years for cancer and now for RA.

http://c.moreover.com/click/here.pl?j477773853&w=464753 ...
Read more : Rituximab / Rituxin | Views : 2416 | Replies : 4


symadex

Read more : symadex | Views : 1398 | Replies : 0


Betaseron for CIS

These stories make me angry and happy at the same tiime. In the last year the CRAB manufacturers have tried to convince us that their therapies should be continued when the dreaded SP MS has been reached, there was news of a trial combining one of the beta-interferons with Copaxone, and now they want us to start them before dx of MS. That's the angry bit - they are trying to milk as much as ...
Read more : Betaseron for CIS | Views : 1355 | Replies : 0


 

Login  •  Register


Statistics

Total posts 224768 • Total topics 23504 • Total members 14895


Contact us | Terms of Service